The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

BACKGROUND: Diabetes mellitus (DM) is a frequent comorbidity in patients with cancer. This study aimed to evaluate the prognosis of advanced non-small cell lung cancer (NSCLC) patients with DM and to assess whether an optimal glycemic control improves overall survival (OS). METHODS: A total of 1279...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jie, Wang, Weimin, Wang, Lin, Lu, Jun, Zhang, Lele, Zhang, Bo, Wang, Shuyuan, Nie, Wei, Zhang, Yanwei, Lou, Yuqing, Han, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635102/
https://www.ncbi.nlm.nih.gov/pubmed/34868942
http://dx.doi.org/10.3389/fonc.2021.745150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635102/
https://www.ncbi.nlm.nih.gov/pubmed/34868942
http://dx.doi.org/10.3389/fonc.2021.745150

Ejemplares similares